This meeting will be held April 18-20, 2016, in Baltimore, MD.
Goals and Objectives
Drug transporter research continues to grow at an unprecedented pace. These rapid advances have been driven, in part, by the emergence of regulatory guidance documents from the FDA, European Medicines Agency (EMA), and Pharmaceuticals and Medical Devices Agency (PMDA) in the last 5 years. Although considerable progress has been made over the past 20 years, the field of drug transport continues to evolve, particularly with respect to clinical translation of preclinical (i.e., in vitro, in vivo, in silico) data, understanding the role of transporter polymorphisms on drug pharmacokinetics, molecular machinery involved in regulation of drug transporters, and the role of transporters in health and disease. The AAPS workshop in 2016 aims to continue on the success of preceding AAPS workshops on drug transporters in ADME meetings (2003, 2005, 2007, 2009, 2011, 2013, 2015) to provide an opportunity for pharmaceutical scientists to exchange ideas and learn novel/cutting edge science in a focused and “state-of-the-art” meeting. More information on the workshop can be found at: http://www.aaps.org/Transporters/.
Who Should Attend
This AAPS/ITC Joint Workshop on Drug Transporters in ADME: From the Bench to the Bedside under the terms set out below is intended for a diverse group of scientists and experts, responsible for the evaluation of safety and efficacy of new drug products, interested parties regarding ongoing efforts on research and development of assays and tools to evaluate the role of transporters in health and disease, and program officers from various regulatory agencies such as FDA, EMA and PMDA.